In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii

Late Onset Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter spp.: Experience with Tigecycline

(2014) D. Curcio et al.   JOURNAL OF CHEMOTHERAPY

Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: results from CAPITAL Surveillance 2010

(2012) Anne Marie Queenan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In VitroPharmacodynamics of Simulated Pulmonary Exposures of Tigecycline Alone and in Combination againstKlebsiella pneumoniaeIsolates Producing a KPC Carbapenemase

(2011) Dora E. Wiskirchen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Changes in MIC Within a Global Collection of Acinetobacter baumannii Collected as Part of the Tigecycline Evaluation and Surveillance Trial, 2004 to 2009

(2011) Rayo Morfin-Otero et al.   CLINICAL THERAPEUTICS

Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU

(2011) Wang-Huei Sheng et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007–09

(2011) Todd A. Davies et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular Epidemiology of Carbapenem-Nonsusceptible Acinetobacter baumannii in the United States

(2011) Jennifer M. Adams-Haduch et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates

(2011) Kyong Ran Peck et al.   JOURNAL OF MEDICAL MICROBIOLOGY

In Vitro Double and Triple Bactericidal Activities of Doripenem, Polymyxin B, and Rifampin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli

(2010) C. Urban et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia

(2010) C. M. Rubino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance

(2010) Nicola C. Gordon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In Vivo Efficacy of 1 and 2g Human Simulated Prolonged Infusion Doripenem against Pseudomonas aeruginosa

(2009) J. L. Crandon et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparison of the Activity of a Human Simulated, High-Dose, Prolonged Infusion of Meropenem against Klebsiella pneumoniae Producing the KPC Carbapenemase versus That against Pseudomonas aeruginosa in an In Vitro Pharmacodynamic Model

(2009) C. C. Bulik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component System

(2009) M. D. Adams et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Selection of colistin-resistant Acinetobacter baumannii isolates in postneurosurgical meningitis in an intensive care unit with high presence of heteroresistance to colistin

(2009) Rodriguez Carlos Hernan et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model

(2009) P. Koomanachai et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

A review of clinical and microbiological outcomes following treatment of infections involving multidrug-resistant Acinetobacter baumannii with tigecycline

(2009) N. C. Gordon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii

(2009) Luigi Principe et al.   Annals of Clinical Microbiology and Antimicrobials

Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options

(2008) Lisa L. Maragakis et al.   CLINICAL INFECTIOUS DISEASES

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

(2008) Alex P. Betrosian et al.   JOURNAL OF INFECTION